DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Sepsis Diagnostics Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Sepsis Diagnostics Market is poised to grow at a CAGR of around 9.9% over the next decade to reach approximately $823.62 billion by 2025.
This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Growing prevalence of sepsis in adult population
Increasing incidence of hospital-acquired infections
Advancements of sepsis diagnostic techniques
- Abbott Diagnostics
- Beckman Coulter (Danaher)
- Becton, Dickinson & Co. (BD)
- Bio-Rad Laboratories
- Bruker Corporation
- Chembio Diagnostic Systems
- Nanosphere, Inc.
- Ortho-Clinical Diagnostics
- Roche Diagnostics
- Siemens Healthcare Diagnostics
- T2 Biosystems, Inc.
- Thermo Fisher Scientific
- Trinity Biotech
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Sepsis Diagnostics Market, By Product
5 Sepsis Diagnostics Market, By Technology
6 Sepsis Diagnostics Market, By Method
7 Sepsis Diagnostics Market, By Pathogen
8 Sepsis Diagnostics Market, By Application
9 Sepsis Diagnostics Market, By End User
10 Sepsis Diagnostics Market, By Geography
11 Key Player Activities
12 Leading Companies
For more information about this report visit http://www.researchandmarkets.com/research/4gq5hp/global_sepsis